ESMO Guidance for Reporting Oncology real-World evidence (GROW)
Luís Castelo-Branco(European Society for Medical Oncology), Miriam Koopman(Radboud University Nijmegen), Tereza Dellaporta(Frontier Science Foundation-Hellas), Anna Pellat(Université Paris Cité), Judith M. Bliss(Institute of Cancer Research), Rolf A. Stahel(International Breast Cancer Study Group), George Pentheroudakis(University of Ioannina), Peter S Hall(Edinburgh Cancer Research), Jeroen W. G. Derksen(Utrecht University), Henrique Martins(Iscte – Instituto Universitário de Lisboa), Antonios Valachis(Örebro University Hospital), Arsela Prelaj(Fondazione IRCCS Istituto Nazionale dei Tumori), Jakob Nikolas Kather(German Cancer Research Center), Arndt Vogel(Medizinische Hochschule Hannover), Suzette Delaloge, Urania Dafni(Frontier Science Foundation-Hellas), Rodrigo Dienstmann(Cancer Research Center), Nuria Ribelles(Instituto de Investigación Biomédica de Málaga), Karijn P.M. Suijkerbuijk(Utrecht University), Christopher M. Booth(Queen's University), Rolf H. H. Groenwold(Leiden University Medical Center), Francesco Perrone(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Diogo Martins-Branco(Université Libre de Bruxelles)
Cited by 209
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
|JAMA|2003|1.4k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k